Risk Paradigm Group’s Halozyme HALO Stock Holding History

Risk Paradigm Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$24.2K	–	257
2016 Q3	$24.2K	Buy	+2,000	New	+$20.4K	0.02%	202

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Risk Paradigm Group's HALO Position: Q4 2016 in Review

Risk Paradigm Group sold out of Halozyme (HALO) in Q4 2016, closing a stake of 2,000 shares — an estimated $24.2K sold.

Risk Paradigm Group first reported a position in HALO in Q3 2016 and held it in 1 quarter. The position peaked at $24.2K in Q3 2016. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

Risk Paradigm Group reported no remaining Halozyme position as of Q4 2016 after selling out during the quarter.
Risk Paradigm Group sold 2,000 Halozyme shares in Q4 2016, an estimated $24.2K.
Risk Paradigm Group first reported a position in Halozyme in Q3 2016 and held it in 1 quarter.
Risk Paradigm Group's Halozyme position peaked at $24.2K in Q3 2016.
168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on Risk Paradigm Group's 13F filing for Q4 2016, filed 13 Feb 2017.